Primordial Genetics Inc has launched its laboratory operations at the JLABS biotechnology incubator on July 19, 2013. The company obtained seed funding from a private investor as well as a Phase I grant from the National Science Foundation. The funds will be used to conduct proof-of-concept work in the baker’s yeast Saccharomyces cerevisiae, to develop novel strains highly resistant to alcohols and environmental stresses for use in fermentation and production of fuels and chemicals.
Primordial Genetics Inc launches R&D operations
Related Posts
“Utilizing the Human Genome to Expand Microbial Potential with Primordial Genomics,” Covered by DNA Weekly
Team PrimordialAugust 4, 2022
Primordial Genetics Receives $55K I-Corps™ at NIH Grant for Enzymatic DNA Synthesis Market Survey
Team PrimordialApril 29, 2021
Primordial Genetics Awarded $1.15M Grant from the National Institute of General Medical Sciences for Revolutionary Ways to Manufacture Therapeutics and Vaccines
Team PrimordialAugust 6, 2020